TIMP3 and RECK have also been reported to mediate the inhibitory effects of interleukin-32α (IL-32α) on endothelial inflammation, smooth muscle cell activation, and atherosclerosis development (Son et al., 2017). The gene discussed is RECK; the disease is atherosclerosis.